Active Clinical Trials

July 3, 2024
July 3, 2024
Categories

Amended Trial: Nataliya Uboha Gives an Update on the EA2183 Trial for Patients with Esophageal and Gastric Adenocarcinoma

The changes broaden eligibility for patients and permit more therapeutic options once enrolled in this randomized phase 3 trial, which explores the addition of radiotherapy to the usual treatment (chemotherapy) in people with esophagus and stomach cancer with limited spread
Do you like it?
0 Read more
March 7, 2024
March 7, 2024
Categories

Now Enrolling: EA5221/ACHIEVE for Older Adults With Advanced Non-Small Cell Lung Cancer

ACHIEVE is the first randomized phase 3 study to focus on older adults with advanced non-small cell lung cancer who are treated with pembrolizumab alone compared to those treated with pembrolizumab plus chemotherapy
Do you like it?
0 Read more
March 7, 2024
Lung x-ray on iPad
March 7, 2024
Categories

Trial Spotlight: Helena Yu Gives an Update on the EA5182 Trial for EGFR-Mutant Non-Small Cell Lung Cancer

This phase 3 randomized controlled trial is comparing first-line treatment with osimertinib plus bevacizumab versus osimertinib alone in patients with metastatic, EGFR-mutant non-small cell lung cancer
Do you like it?
0 Read more
December 19, 2023
December 19, 2023
Categories

Now Enrolling: EA2222/PUMP for Patients With Colorectal Cancer That Has Spread to the Liver

This randomized phase 3 trial is testing whether second-line treatment with hepatic arterial infusion and systemic chemotherapy is more effective than systemic chemotherapy alone
Do you like it?
0 Read more
12345678